公开(公告)号：US20230255515A1

公开(公告)日：2023-08-17

申请号：US18306086

申请日：2023-04-24

申请人： Abbott Diabetes Care Inc.

发明人： Mark K. SLOAN ,  Royce CHENG ,  Gary A. HAYTER ,  Marc B. TAUB ,  Mani GOPAL

IPC分类号： A61B5/145 ,  G16H40/63 ,  G16H10/40 ,  A61B5/00

CPC分类号： A61B5/145 ,  G16H40/63 ,  G16H10/40 ,  A61B5/7221 ,  A61B5/14532 ,  A61B5/1495

摘要： Generally, methods, devices, and systems related to analyte monitoring and data logging are provided—e.g., as related to in vivo analyte monitoring devices and systems. In some aspects, methods, devices, and systems are provided that relate to enable related settings based on an expected use of an in vivo positioned sensor; logging or otherwise recording analyte levels acquired or derived—e.g., sample analyte levels more frequently than they are logged or otherwise recorded in memory; dynamically adjust the data logging frequency; randomly determine times of acquiring or storing analyte levels from the in-vivo positioned analyte sensors; and enable recording related settings when the system is operable.